Suppr超能文献

人类可溶性环氧化物水解酶基因EPHX2的转录调控

Transcriptional regulation of the human soluble epoxide hydrolase gene EPHX2.

作者信息

Tanaka Hiromasa, Kamita Shizuo G, Wolf Nicola M, Harris Todd R, Wu Zhaoju, Morisseau Christophe, Hammock Bruce D

机构信息

Department of Entomology and the Cancer Research Center, University of California, Davis, CA 95616, USA.

出版信息

Biochim Biophys Acta. 2008 Jan;1779(1):17-27. doi: 10.1016/j.bbagrm.2007.11.005. Epub 2007 Dec 3.

Abstract

Soluble epoxide hydrolase (sEH) is a multifunctional protein encoded by the EPHX2 gene. The biological functions and enzyme kinetics of sEH have been extensively investigated, however, little is known about its transcriptional regulation and mechanisms of tissue specific expression. Here, a luciferase gene based reporter assay was used to identify the minimal promoter and cis regulatory elements of EPHX2. The minimal promoter was identified as a GC-rich region between nts -374 and +28 with respect to the putative transcriptional start site. A reporter plasmid carrying this minimal promoter showed higher or similar activities in comparison to a reporter plasmid carrying nts -5,974 to +28 of EPHX2 in 9 human cell lines that were tested. Sp1 binding sites that are involved in augmenting the minimal promoter activity of EPHX2 were identified by nested deletion analysis, site-specific mutation, electrophoretic mobility shift assay, and chromatin immunoprecipitation assay.

摘要

可溶性环氧化物水解酶(sEH)是一种由EPHX2基因编码的多功能蛋白质。sEH的生物学功能和酶动力学已得到广泛研究,然而,关于其转录调控和组织特异性表达机制却知之甚少。在此,基于荧光素酶基因的报告基因检测被用于鉴定EPHX2的最小启动子和顺式调控元件。最小启动子被确定为相对于假定转录起始位点在nts -374至+28之间的富含GC的区域。在9种测试的人类细胞系中,携带该最小启动子的报告质粒与携带EPHX2的nts -5,974至+28的报告质粒相比,表现出更高或相似的活性。通过巢式缺失分析、位点特异性突变、电泳迁移率变动分析和染色质免疫沉淀分析,鉴定出了参与增强EPHX2最小启动子活性的Sp1结合位点。

相似文献

1
Transcriptional regulation of the human soluble epoxide hydrolase gene EPHX2.
Biochim Biophys Acta. 2008 Jan;1779(1):17-27. doi: 10.1016/j.bbagrm.2007.11.005. Epub 2007 Dec 3.
2
Down-regulation of EPHX2 gene transcription by Sp1 under high-glucose conditions.
Biochem J. 2015 Sep 15;470(3):281-91. doi: 10.1042/BJ20150397. Epub 2015 Jul 15.
4
Sp1 is required for glucose-induced transcriptional regulation of mouse vesicular glutamate transporter 2 gene.
Gastroenterology. 2008 Jun;134(7):1994-2003. doi: 10.1053/j.gastro.2008.02.076. Epub 2008 Feb 29.
6
Sp1 site is crucial for the mouse claudin-19 gene expression in the kidney cells.
FEBS Lett. 2004 Dec 17;578(3):251-6. doi: 10.1016/j.febslet.2004.11.010.
7
Estrogen-dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation.
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):613-618. doi: 10.1073/pnas.1716016115. Epub 2018 Jan 2.
8
Transcription of the human microsomal epoxide hydrolase gene (EPHX1) is regulated by an HNF-4α/CAR/RXR/PSF complex.
Biochim Biophys Acta. 2013 Oct;1829(10):1000-9. doi: 10.1016/j.bbagrm.2013.05.003. Epub 2013 May 26.
9
Functional and sequence analysis of human neuroglobin gene promoter region.
Biochim Biophys Acta. 2011 Apr-Jun;1809(4-6):236-44. doi: 10.1016/j.bbagrm.2011.02.003. Epub 2011 Mar 9.
10
DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism.
Biochim Biophys Acta. 2010 Sep;1799(9):659-67. doi: 10.1016/j.bbagrm.2010.09.006. Epub 2010 Oct 1.

引用本文的文献

1
A regulatory loop involving the cytochrome P450-soluble epoxide hydrolase axis and TGF-β signaling.
iScience. 2024 Sep 16;27(10):110938. doi: 10.1016/j.isci.2024.110938. eCollection 2024 Oct 18.
2
Multi-Target Approaches in Metabolic Syndrome.
Front Pharmacol. 2021 Mar 12;11:554961. doi: 10.3389/fphar.2020.554961. eCollection 2020.
3
Clinical significance of EPHX2 deregulation in prostate cancer.
Asian J Androl. 2021 Jan-Feb;23(1):109-115. doi: 10.4103/aja.aja_34_20.
5
Increased Soluble Epoxide Hydrolase in Human Gestational Tissues from Pregnancies Complicated by Acute Chorioamnionitis.
Mediators Inflamm. 2019 Dec 5;2019:8687120. doi: 10.1155/2019/8687120. eCollection 2019.
6
Effect of Soluble Epoxide Hydrolase in Hyperoxic Acute Lung Injury in Mice.
Inflammation. 2018 Jun;41(3):1065-1072. doi: 10.1007/s10753-018-0758-y.
7
Estrogen-dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation.
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):613-618. doi: 10.1073/pnas.1716016115. Epub 2018 Jan 2.
10
Epoxygenated Fatty Acids Inhibit Retinal Vascular Inflammation.
Sci Rep. 2016 Dec 14;6:39211. doi: 10.1038/srep39211.

本文引用的文献

1
Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation.
Resuscitation. 2008 Jan;76(1):89-94. doi: 10.1016/j.resuscitation.2007.06.031. Epub 2007 Aug 28.
2
Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.
Proc Natl Acad Sci U S A. 2007 May 22;104(21):9018-23. doi: 10.1073/pnas.0703229104. Epub 2007 May 10.
3
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors.
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18733-8. doi: 10.1073/pnas.0609158103. Epub 2006 Nov 27.
5
Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms.
J Mol Histol. 2006 May;37(3-4):133-41. doi: 10.1007/s10735-006-9050-9. Epub 2006 Sep 7.
6
Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues.
J Histochem Cytochem. 2006 Mar;54(3):329-35. doi: 10.1369/jhc.5A6808.2005. Epub 2005 Nov 28.
7
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.
Hypertension. 2005 Oct;46(4):975-81. doi: 10.1161/01.HYP.0000176237.74820.75. Epub 2005 Sep 12.
9
Soluble epoxide hydrolase is a therapeutic target for acute inflammation.
Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9772-7. doi: 10.1073/pnas.0503279102. Epub 2005 Jun 30.
10
Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles.
Annu Rev Pharmacol Toxicol. 2005;45:311-33. doi: 10.1146/annurev.pharmtox.45.120403.095920.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验